Mackenzie Financial Corp Athersys, Inc Transaction History

Mackenzie Financial Corp

  • $66.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.18 - $0.86 $2,024 - $9,674
-11,249 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.4 $485 - $799
-571 Reduced 4.83%
11,249 $10,000
Q3 2021

Nov 08, 2021
BUY
$1.33 - $1.77 $15,720 - $20,921
11,820 New
11,820 $16,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email